2,4,6-Tris(3,4,5-trifluorophenyl)boroxin>98.0%(T)5g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoic acid, 95%, 5g

(3s,4s,6r)-3-Hexyl-4-hydroxy-6-undecyl-tetrahydropyran-2-one, 95+%, 250mg

4-Chloro-6,7-dihydroxyquinoline-3-carbonitrile, 98%, 1g

(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine hydrochloride, 100mg

Propylenglykolmonobutylether, min 99 %, zur Synthese, 2.5 l, kunststoffverpackung.

1H-Benzo[d]imidazole-4-carbaldehyde, 95.0%, 25g

3-Bromo-2-oxo-butyric acid ethyl ester, 95.0%, 250mg

Methyl 5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole-3-carboxylate, 98%, 1g

(S)-tert-Butyl (2-(pyrrolidin-2-yl)ethyl)carbamate, 95.0%, 1g

3,4-Difluorotoluene, 98.0%, 25g

2-Chloro-N-2-pyrimidinylacetamide, 98%, 5g

Tubocurarine Chloride Pentahydrate>98.0%(HPLC)(T)100mg